Hyaluronic Acid Fillers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report View Sample

Published: March 29, 2024 Report Code: GDME1726EPD-ST

Select Item

Hyaluronic Acid Fillers Pipeline Market Report Overview

Hyaluronic Acid (HA) is a glycosaminoglycan disaccharide, which exists naturally in the body. Approximately 50% of the total HA is found in the skin. Injections of HA are used for reducing wrinkles in the face and for soft tissue augmentation.

The hyaluronic acid fillers pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segments ·        Biphasic Hyaluronic Acid Fillers

·        Monophasic Hyaluronic Acid Fillers
Key Territories ·        The US

·        Europe

·        China

·        South Korea

·        Hong Kong
Key Regulatory Paths ·        PMA

·        CE

·        NMPA

·        NIFDS

·        510(k)
Leading Companies ·        Allergan Aesthetics

·        Almirall Ltd

·        Aquavit Pharmaceuticals Inc

·        BioPlus Co Ltd

·        CollPlant Biotechnologies Ltd
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Hyaluronic Acid Fillers Pipeline Market Segmentation by Segments

The key segments for the hyaluronic acid fillers pipeline market are biphasic hyaluronic acid fillers and monophasic hyaluronic acid fillers. As of March 2024, biphasic hyaluronic acid fillers accounted for the highest share of pipeline products.

Hyaluronic Acid Fillers Pipeline Market Analysis by Segments, 2024 (%)

Hyaluronic Acid Fillers Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segment Insights into the Hyaluronic Acid Fillers Pipeline Market

Download a Free Report Sample

Hyaluronic Acid Fillers Pipeline Market Segmentation by Territories

A few of the key territories for the hyaluronic acid fillers pipeline market are the US, Europe, China, South Korea, and Hong Kong. As of March 2024, the US accounted for the highest number of pipeline products.

Hyaluronic Acid Fillers Pipeline Market Analysis by Territories, 2024 (%)

Hyaluronic Acid Fillers Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Hyaluronic Acid Fillers Pipeline Market

Download a Free Report Sample

Hyaluronic Acid Fillers Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the hyaluronic acid fillers pipeline products market are PMA, CE, NMPA, NIFDS, and 510(k). As of March 2024, PMA was the most followed pathway for pipeline products in the market.

Hyaluronic Acid Fillers Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Hyaluronic Acid Fillers Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Hyaluronic Acid Fillers Pipeline Market

Download a Free Report Sample

Hyaluronic Acid Fillers Pipeline Market – Competitive Landscape

A few of the key companies associated with the hyaluronic acid fillers pipeline market are Allergan Aesthetics, Almirall Ltd, Aquavit Pharmaceuticals Inc, BioPlus Co Ltd, CollPlant Biotechnologies Ltd, among others.

Almirall Ltd: It is headquartered in Uxbridge, Middlesex, the UK. Almirall is a biopharmaceutical company that develops healthcare solutions for dermatology indications. The company offers actikerall cutaneous solution, aknemycin plus cutaneous solution, and balenum dry skin and itch relief cream, among other other products.

CollPlant Biotechnologies Ltd: CollPlant is headquartered in Rehovot, Israel. It is a regenerative and aesthetic medicine company that focuses on developing technologies and products for tissue regeneration and organ manufacturing. The company’s rhCollagen technology is also used in its commercial products, which are available in the European market. CollPlant’s products are used in various applications, including drug discovery, personalized medicine, and medical aesthetics.

Hyaluronic Acid Fillers Pipeline Market Analysis by Companies, 2024

Hyaluronic Acid Fillers Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Hyaluronic Acid Fillers Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Hyaluronic Acid Fillers Pipeline Market Segments Outlook

  • Biphasic Hyaluronic Acid Fillers
  • Monophasic Hyaluronic Acid Fillers

Hyaluronic Acid Fillers Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • South Korea
  • Hong Kong

Hyaluronic Acid Fillers Pipeline Market Regulatory Paths Outlook

  • PMA
  • CE
  • NMPA
  • NIFDS
  • 510(k)

Scope

This report provides:

  • Extensive coverage of the hyaluronic acid fillers under development.

  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.

  • Reviews of major players involved in the development of hyaluronic acid fillers and lists all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • Key clinical trial data of ongoing clinical trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.

  • Identify and understand important and diverse types of hyaluronic acid fillers under development.

  • Develop market-entry and market-expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Allergan Aesthetics
Almirall Ltd
Aquavit Pharmaceuticals Inc
BioPlus Co Ltd
BioSmart Nanotechnology Ltda
BMG Pharma SpA
Bmi Korea Co Ltd
CellPraxis
Collplant Biotechnologies Ltd
Croma-Pharma GmbH
Evolus Inc
Fillmed Laboratoires
Hallura Ltd
Hugel Inc
Jinwoo Bio Co Ltd
Laboratoires Vivacy
LG Chem Ltd
LifeSprout Inc
Medytox Inc
Merz Aesthetics
Mesoestetic Pharma Group SL
Oligo Medic Inc
Q-Med AB
Shanghai Haohai Biological Technology Co Ltd
Shin Poong Pharm Co Ltd
Silk Medical Aesthetics Inc
Sinclair Pharma Ltd
SwiftPharma BV
Teoxane SA
Tissueform Inc
TruElastin Laboratories Inc

Table of Contents

1 Table of Contents 3

1.1 List of Tables 6

1.2 List of Figures 10

2 Introduction 11

2.1 Hyaluronic Acid Fillers Overview 11

3 Products under Development 12

3.1 Hyaluronic Acid Fillers – Pipeline Products by Stage of Development 12

3.2 Hyaluronic Acid Fillers – Pipeline Products by Segment 13

3.3 Hyaluronic Acid Fillers – Pipeline Products by Territory 14

3.4 Hyaluronic Acid Fillers – Pipeline Products by Regulatory Path 15

3.5 Hyaluronic Acid Fillers – Pipeline Products by Estimated Approval Date 16

3.6 Hyaluronic Acid Fillers – Ongoing Clinical Trials 17

4 Hyaluronic Acid Fillers – Pipeline Products under Development by Companies 18

4.1 Hyaluronic Acid Fillers Companies – Pipeline Products by Stage of Development 18

4.2 Hyaluronic Acid Fillers – Pipeline Products by Stage of Development 20

5 Hyaluronic Acid Fillers Companies and Product Overview 22

5.1 Allergan Aesthetics Company Overview 22

5.1.1 Allergan Aesthetics Pipeline Products & Ongoing Clinical Trials Overview 22

5.2 Almirall Ltd Company Overview 28

5.2.1 Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview 28

5.3 Aquavit Pharmaceuticals Inc Company Overview 29

5.3.1 Aquavit Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 29

5.4 BioPlus Co Ltd Company Overview 30

5.4.1 BioPlus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

5.5 BioSmart Nanotechnology Ltda Company Overview 33

5.5.1 BioSmart Nanotechnology Ltda Pipeline Products & Ongoing Clinical Trials Overview 33

5.6 BMG Pharma SpA Company Overview 34

5.6.1 BMG Pharma SpA Pipeline Products & Ongoing Clinical Trials Overview 34

5.7 Bmi Korea Co Ltd Company Overview 36

5.7.1 Bmi Korea Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

5.8 CellPraxis Company Overview 37

5.8.1 CellPraxis Pipeline Products & Ongoing Clinical Trials Overview 37

5.9 Collplant Biotechnologies Ltd Company Overview 38

5.9.1 Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 38

5.10 Croma-Pharma GmbH Company Overview 39

5.10.1 Croma-Pharma GmbH Pipeline Products & Ongoing Clinical Trials Overview 39

5.11 Evolus Inc Company Overview 42

5.11.1 Evolus Inc Pipeline Products & Ongoing Clinical Trials Overview 42

5.12 Fillmed Laboratoires Company Overview 46

5.12.1 Fillmed Laboratoires Pipeline Products & Ongoing Clinical Trials Overview 46

5.13 Hallura Ltd Company Overview 48

5.13.1 Hallura Ltd Pipeline Products & Ongoing Clinical Trials Overview 48

5.14 Hugel Inc Company Overview 50

5.14.1 Hugel Inc Pipeline Products & Ongoing Clinical Trials Overview 50

5.15 Jinwoo Bio Co Ltd Company Overview 54

5.15.1 Jinwoo Bio Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 54

5.16 Laboratoires Vivacy Company Overview 57

5.16.1 Laboratoires Vivacy Pipeline Products & Ongoing Clinical Trials Overview 57

5.17 LG Chem Ltd Company Overview 60

5.17.1 LG Chem Ltd Pipeline Products & Ongoing Clinical Trials Overview 60

5.18 LifeSprout Inc Company Overview 69

5.18.1 LifeSprout Inc Pipeline Products & Ongoing Clinical Trials Overview 69

5.19 Medytox Inc Company Overview 72

5.19.1 Medytox Inc Pipeline Products & Ongoing Clinical Trials Overview 72

5.20 Merz Aesthetics Company Overview 74

5.20.1 Merz Aesthetics Pipeline Products & Ongoing Clinical Trials Overview 74

5.21 Mesoestetic Pharma Group SL Company Overview 75

5.21.1 Mesoestetic Pharma Group SL Pipeline Products & Ongoing Clinical Trials Overview 75

5.22 Oligo Medic Inc Company Overview 77

5.22.1 Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview 77

5.23 Q-Med AB Company Overview 78

5.23.1 Q-Med AB Pipeline Products & Ongoing Clinical Trials Overview 78

5.24 Shanghai Haohai Biological Technology Co Ltd Company Overview 79

5.24.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 79

5.25 Shin Poong Pharm Co Ltd Company Overview 80

5.25.1 Shin Poong Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 80

5.26 Silk Medical Aesthetics Inc Company Overview 81

5.26.1 Silk Medical Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview 81

5.27 Sinclair Pharma Ltd Company Overview 83

5.27.1 Sinclair Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 83

5.28 SwiftPharma BV Company Overview 88

5.28.1 SwiftPharma BV Pipeline Products & Ongoing Clinical Trials Overview 88

5.29 Teoxane SA Company Overview 89

5.29.1 Teoxane SA Pipeline Products & Ongoing Clinical Trials Overview 89

5.30 Tissueform Inc Company Overview 92

5.30.1 Tissueform Inc Pipeline Products & Ongoing Clinical Trials Overview 92

5.31 TruElastin Laboratories Inc Company Overview 93

5.31.1 TruElastin Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 93

6 Hyaluronic Acid Fillers- Recent Developments 94

6.1 Mar 05, 2024: JUVEDERM VOLUMA XC For Temple Hollows Receives U.S. FDA Approval 94

6.2 Mar 05, 2024: JUVÉDERM VOLUMA XC For Temple Hollows Receives U.S. FDA Approval 95

6.3 Mar 04, 2024: Revance Therapeutics Announces Proposed $100M Share Offering 96

6.4 Mar 01, 2024: Evolus Announces Results from European Head-to-Head Filler Trial 96

6.5 Feb 27, 2024: Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024 97

6.6 Feb 27, 2024: LG Chem to Raise 1 tln Won in Bond Sale 97

6.7 Feb 22, 2024: AbbVie Selling $15 Billion Bonds to Buy ImmunoGen, Cerevel 97

6.8 Feb 07, 2024: Galderma Launches ‘Next’, a Ground-Breaking Trend Report That Unveils the Future of Aesthetics 97

6.9 Feb 05, 2024: AbbVie’s Full Year 2023 Sees

6.4% Net Revenue Drop 98

6.10 Jan 22, 2024: Galderma Announces Regulatory Approval for Restylane SHAYPE, a new Hyaluronic Acid Injectable Designed for Augmenting the Chin Region 99

6.11 Jan 04, 2024: AbbVie to Host Full-Year and Fourth-Quarter 2023 Earnings Conference Call 99

6.12 Jan 03, 2024: Medytox Announces Executive Appointments in Luvantas, Inc 100

6.13 Nov 01, 2023: CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler 100

6.14 Oct 31, 2023: SKINVIVE by JUVEDERM Now Available from Dermatologist Dr. Ellen Turner 100

6.15 Oct 31, 2023: LG Chem Announces 3Q Management Performance 101

6.16 Oct 10, 2023: Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023 101

6.17 Oct 04, 2023: AbbVie to Host Third-Quarter 2023 Earnings Conference Call 102

6.18 Sep 28, 2023: Merz Aesthetics Continues to Fuel Confidence by Expanding Belotero Balance (+) Filler Treatment Areas 102

6.19 Sep 19, 2023: Revance Provides Corporate Update at Investor Day 103

6.20 Sep 01, 2023: Shanghai Haohai Biological Technology Co. Announces Interim Report 2023 104

6.21 Aug 24, 2023: CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million 104

6.22 Aug 01, 2023: Allergan Aesthetics Announces First Ever JUVEDERM Day 108

6.23 Jun 26, 2023: Collplant Achieves Milestone and to Receive $10 Million From Abbvie in Accordance With Its Regenerative Dermal Filler Product Collaboration Agreement 109

6.24 Jun 12, 2023: Croma-Pharma announces enrollment of first patient in hyaluronic acid dermal filler clinical trial in China 109

6.25 May 15, 2023: SKINVIVE by JUVÉDERM receives U.S. FDA approval 110

7 Appendix 112

7.1 Methodology 112

7.2 About GlobalData 115

7.3 Contact Us 115

7.4 Disclaimer 115

Table

Hyaluronic Acid Fillers – Pipeline Products by Stage of Development 12

Hyaluronic Acid Fillers – Pipeline Products by Segment 13

Hyaluronic Acid Fillers – Pipeline Products by Territory 14

Hyaluronic Acid Fillers – Pipeline Products by Regulatory Path 15

Hyaluronic Acid Fillers – Pipeline Products by Estimated Approval Date 16

Hyaluronic Acid Fillers – Ongoing Clinical Trials 17

Hyaluronic Acid Fillers Companies – Pipeline Products by Stage of Development 18

Hyaluronic Acid Fillers – Pipeline Products by Stage of Development 20

Allergan Aesthetics Pipeline Products & Ongoing Clinical Trials Overview 22

HA Threads – Product Status 22

HA Threads – Product Description 22

Juvederm – Decolletage – Product Status 23

Juvederm – Decolletage – Product Description 23

Juvederm – Hands – Product Status 23

Juvederm – Hands – Product Description 23

Juvederm Voluma – Nose – Product Status 24

Juvederm Voluma – Nose – Product Description 24

Juvederm Voluma Global – Malar Augmentation – Product Status 24

Juvederm Voluma Global – Malar Augmentation – Product Description 24

JUVEDERM VOLUMA XC – Temple Augmentation – Product Status 25

JUVEDERM VOLUMA XC – Temple Augmentation – Product Description 25

Allergan Aesthetics – Ongoing Clinical Trials Overview 26

Juvederm Voluma Global – Malar Augmentation – Clinical, Instrumental and Histological Evaluation of the Combined Use of Onabotulinumtoxin A and Hyaluronic Acid Fillers in Patients with Facial Paralysis 27

Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview 28

Hyaluronic Acid Facial Filler – Product Status 28

Hyaluronic Acid Facial Filler – Product Description 28

Aquavit Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 29

Aquabelo – Product Status 29

Aquabelo – Product Description 29

BioPlus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

HyalDew All – Product Status 30

HyalDew All – Product Description 30

HyalDew Fine – Product Status 31

HyalDew Fine – Product Description 31

HyalDew Shine – Product Status 31

HyalDew Shine – Product Description 32

HyalDew-Mid – Product Status 32

HyalDew-Mid – Product Description 32

BioSmart Nanotechnology Ltda Pipeline Products & Ongoing Clinical Trials Overview 33

Hyaluronic Acid Dermal Filler – Product Status 33

Hyaluronic Acid Dermal Filler – Product Description 33

BMG Pharma SpA Pipeline Products & Ongoing Clinical Trials Overview 34

SGA300 – Product Status 34

SGA300 – Product Description 34

SGA302 – Product Status 35

SGA302 – Product Description 35

Bmi Korea Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

BMI4002 – Product Status 36

BMI4002 – Product Description 36

CellPraxis Pipeline Products & Ongoing Clinical Trials Overview 37

Lipage – Product Status 37

Lipage – Product Description 37

Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 38

rhCollagen Based Photocurable Regenerative Dermal Filler – Product Status 38

rhCollagen Based Photocurable Regenerative Dermal Filler – Product Description 38

Croma-Pharma GmbH Pipeline Products & Ongoing Clinical Trials Overview 39

Saypha Volume Plus Lidocaine – Product Status 39

Saypha Volume Plus Lidocaine – Product Description 39

Croma-Pharma GmbH – Ongoing Clinical Trials Overview 40

Saypha Volume Plus Lidocaine – A Randomized, Multi-center, Evaluator-blinded, Parallel Assignment, Active Controlled Study to Evaluate the Efficacy and Safety of Princess Voluma plus and Restylane Perlane Lidocaine for Correction of Midface Volume Deficit And/Or Midface Contour Deficiency 41

Evolus Inc Pipeline Products & Ongoing Clinical Trials Overview 42

Evolysse Eye Infraorbital Hollows Filler – Product Status 42

Evolysse Eye Infraorbital Hollows Filler – Product Description 43

Evolysse Lift Nasolabial Folds Filler – Product Status 43

Evolysse Lift Nasolabial Folds Filler – Product Description 43

Evolysse Lips Volumizing And Countering Filler – Product Status 44

Evolysse Lips Volumizing And Countering Filler – Product Description 44

Evolysse Sculpt Mid Face Volume Filler – Product Status 44

Evolysse Sculpt Mid Face Volume Filler – Product Description 45

Evolysse Smooth Nasolabial Folds Filler – Product Status 45

Evolysse Smooth Nasolabial Folds Filler – Product Description 45

Fillmed Laboratoires Pipeline Products & Ongoing Clinical Trials Overview 46

NCTF 135 – Product Status 46

NCTF 135 – Product Description 46

NCTF 135 HA – Product Status 47

NCTF 135 HA – Product Description 47

Hallura Ltd Pipeline Products & Ongoing Clinical Trials Overview 48

BiOLinkMatrix Gel – Product Status 48

BiOLinkMatrix Gel – Product Description 48

Hyaluronic Acid Dermal Filler – Product Status 49

Hyaluronic Acid Dermal Filler – Product Description 49

Hugel Inc Pipeline Products & Ongoing Clinical Trials Overview 50

The Chaeum Pure No.1 – Product Status 50

The Chaeum Pure No.1 – Product Description 51

The Chaeum Pure No.2 – Product Status 51

The Chaeum Pure No.2 – Product Description 51

The Chaeum Pure No.3 – Product Status 52

The Chaeum Pure No.3 – Product Description 52

The Chaeum Pure No.4 – Product Status 52

The Chaeum Pure No.4 – Product Description 53

The Chaeum Style – Product Status 53

The Chaeum Style – Product Description 53

Jinwoo Bio Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 54

HA Filler – Product Status 54

HA Filler – Product Description 54

HA Thread Filler – Product Status 55

HA Thread Filler – Product Description 55

Wool Filler – Product Status 56

Wool Filler – Product Description 56

Laboratoires Vivacy Pipeline Products & Ongoing Clinical Trials Overview 57

IPN-21-SENSE Dermal Filler – Product Status 57

IPN-21-SENSE Dermal Filler – Product Description 57

Laboratoires Vivacy – Ongoing Clinical Trials Overview 58

IPN-21-SENSE Dermal Filler – A Multicenter, Prospective, Randomized Controlled Clinical Study of IPN-21-SENSE, a Novel Hyaluronic Acid Based Gel for Volume Deficiency in the Mid-face 59

LG Chem Ltd Pipeline Products & Ongoing Clinical Trials Overview 60

Dermal Filler (LR19093) – Product Status 60

Dermal Filler (LR19093) – Product Description 61

Hyaluronic Acid Filler (LR19094) – Product Status 61

Hyaluronic Acid Filler (LR19094) – Product Description 61

Hyaluronic Acid Filler (LR20023) – Product Status 61

Hyaluronic Acid Filler (LR20023) – Product Description 62

Hyaluronic Acid Filler (LR20024) – Product Status 62

Hyaluronic Acid Filler (LR20024) – Product Description 62

Next Generation Hyaluronic Acid Filler (LR20008) – Product Status 63

Next Generation Hyaluronic Acid Filler (LR20008) – Product Description 63

YVOIRE Y-Solution 360 – Product Status 63

YVOIRE Y-Solution 360 – Product Description 64

YVOIRE Y-Solution 540 – Product Status 64

YVOIRE Y-Solution 540 – Product Description 64

YVOIRE Y-Solution 720 – Product Status 65

YVOIRE Y-Solution 720 – Product Description 65

LG Chem Ltd – Ongoing Clinical Trials Overview 66

YVOIRE Y-Solution 360 – A Multicenter, Randomized, Rater-Blinded, No-Treatment Control Design Clinical Investigation to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 360 for Lip Augmentation 67

YVOIRE Y-Solution 540 – A Randomized, Multicenter, Evaluator-blinded, Active-controlled, Parallel-group Design Investigation to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 540 Versus YVOIRE Volume Plus in Nasolabial Folds Injection 68

LifeSprout Inc Pipeline Products & Ongoing Clinical Trials Overview 69

Lumina – Product Status 69

Lumina – Product Description 69

LifeSprout Inc – Ongoing Clinical Trials Overview 70

Lumina – A Prospective, Randomized, Controlled, Multi-center Study of the Safety and Effectiveness of Lumina in the Treatment of Nasolabial Folds 71

Medytox Inc Pipeline Products & Ongoing Clinical Trials Overview 72

Neuramis Deep Lidocaine – Product Status 72

Neuramis Deep Lidocaine – Product Description 72

Neuramis Volume Lidocaine – Product Status 73

Neuramis Volume Lidocaine – Product Description 73

Merz Aesthetics Pipeline Products & Ongoing Clinical Trials Overview 74

VP1 Lido US – Product Status 74

VP1 Lido US – Product Description 74

Mesoestetic Pharma Group SL Pipeline Products & Ongoing Clinical Trials Overview 75

LIFT001 – Product Status 75

LIFT001 – Product Description 75

mRDX-02-17 – Product Status 76

mRDX-02-17 – Product Description 76

Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview 77

AntaRep – Product Status 77

AntaRep – Product Description 77

Q-Med AB Pipeline Products & Ongoing Clinical Trials Overview 78

GAL1906 – Product Status 78

GAL1906 – Product Description 78

Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 79

Organic Cross-Linked HA Dermal Filler – Product Status 79

Organic Cross-Linked HA Dermal Filler – Product Description 79

Shin Poong Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 80

FreeWink – Product Status 80

FreeWink – Product Description 80

Silk Medical Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview 81

Dermal Filler – Product Status 81

Dermal Filler – Product Description 81

SMA-001 – Product Status 82

SMA-001 – Product Description 82

Sinclair Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 83

Atlean – Product Status 83

Atlean – Product Description 83

MaiLi – Product Status 84

MaiLi – Product Description 84

MaiLi Extreme – Product Status 84

MaiLi Extreme – Product Description 85

Perfectha G – Product Status 85

Perfectha G – Product Description 85

Sinclair Pharma Ltd – Ongoing Clinical Trials Overview 86

MaiLi Extreme – A Post Market Clinical Follow Up (PMCF) Study to Assess the Safety and Efficacy of MaiLi Volume and MaiLi Extreme in the Treatment of Temporal Hollowing, Mid-Face Volume Deficit, Jawline Ptosis, and Chin Retrusion 87

SwiftPharma BV Pipeline Products & Ongoing Clinical Trials Overview 88

Injectable Dermal Filler – Product Status 88

Injectable Dermal Filler – Product Description 88

Teoxane SA Pipeline Products & Ongoing Clinical Trials Overview 89

Teosyal RHA 1 – Product Status 89

Teosyal RHA 1 – Product Description 89

Teoxane SA – Ongoing Clinical Trials Overview 90

Teosyal RHA 1 – A Prospective, Single Blind, Single-center Study Evaluating the Histology and Intradermal Implantation of the Teosyal RHA Collection of Fillers 91

Tissueform Inc Pipeline Products & Ongoing Clinical Trials Overview 92

PureVoluma – Product Status 92

PureVoluma – Product Description 92

TruElastin Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 93

TEL219 – Product Status 93

TEL219 – Product Description 93

Glossary 114

Figures

Hyaluronic Acid Fillers – Pipeline Products by Stage of Development 12

Hyaluronic Acid Fillers – Pipeline Products by Segment 13

Hyaluronic Acid Fillers – Pipeline Products by Territory 14

Hyaluronic Acid Fillers – Pipeline Products by Regulatory Path 15

Hyaluronic Acid Fillers – Pipeline Products by Estimated Approval Date 16

Hyaluronic Acid Fillers – Ongoing Clinical Trials 17

Frequently asked questions

Hyaluronic Acid Fillers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Hyaluronic Acid Fillers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Hyaluronic Acid Fillers reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Hyaluronic Acid Fillers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Hyaluronic Acid Fillers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more